HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Zhao-Wei Wang Selected Research

2-imidazoline

3/20112-BFI attenuates experimental autoimmune encephalomyelitis-induced spinal cord injury with enhanced B-CK, CaATPase, but reduced calpain activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Zhao-Wei Wang Research Topics

Disease

2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
10/2012 - 03/2011
1Body Weight (Weight, Body)
10/2012
1Brain Injuries (Brain Injury)
10/2012
1Neuroinflammatory Diseases
10/2012
1Demyelinating Diseases (Demyelinating Disease)
10/2012
1Multiple Sclerosis
10/2012
1Spinal Cord Injuries (Spinal Cord Injury)
03/2011

Drug/Important Bio-Agent (IBA)

1CytokinesIBA
10/2012
1Purinergic P1 Receptors (Adenosine Receptor)IBA
10/2012
1Adenosine A2A Receptor (Adenosine A2A Receptors)IBA
10/2012
1Glycoproteins (Glycoprotein)IBA
10/2012
1Adenosine (Adenocard)FDA LinkGeneric
10/2012
1Peptides (Polypeptides)IBA
10/2012
1Imidazoline ReceptorsIBA
03/2011
12-(2-benzofuranyl)-2-imidazolineIBA
03/2011
1CalpainIBA
03/2011
1LigandsIBA
03/2011
12-imidazolineIBA
03/2011